SERPINC1 and hepatocellular carcinoma: In cirrhotic patients with PVT—40% of whom had HCC—plasma ATIII levels < 54% were associated with significantly worse 5-year survival (HR 3.68; 95% CI 1.66–8.16; p = 0.0013).